Foley Partner Courtenay Brinckerhoff was quoted in an article that appeared in The New York Times on December 17, 2010 titled “Court Backs Patents for Diagnostic Tests.” Brinckerhoff discusses a Court of Appeals for the Federal Circuit ruling which upholds that diagnostic tests used to determine whether a patient is getting the proper dose of a medicine can be patented. She states that the decision will be welcomed by those working in personalized medicine and may help improve both the clinical efficacy and cost-efficiency of therapeutic treatment.
People
Related News
April 13, 2026
In the News
Increase in Demand and Firm Growth Led Foley to Large Leaps in Revenue and PEP in a 'Year When It All Came Together'
Foley & Lardner LLP saw double-digit increases and all-time highs across all financial metrics in 2025 as noted in The American Lawyer article, “Foley Grows Revenue by Nearly 14%, PEP by 27%, in a 'Year When It All Came Together'.”
April 10, 2026
In the News
Foley's Texas Media Roundtable Highlighted for Insights on Today's Energy Transformations
Foley & Lardner LLP is featured across media for the firm’s recent roundtable discussion on energy trends related to grid reliability, data centers, and capital investments.
April 10, 2026
In the News
Deanna Reitman and Glenn Reitman Highlighted Across Media for Foley Arrival
Foley & Lardner LLP partners Deanna Reitman and Glenn Reitman attracted widespread media coverage for their recent arrival to the firm’s Houston office.